Biotech Startups

Amplify Dynamics develops an ultrasound-based, contactless purification system for lipid nanoparticles (LNPs) used in therapeutics, aimed at increasing particle recovery, throughput, and sustainability compared to membrane-based methods. It serves therapeutic discovery and pharmaceutical production workflows.

1 investor

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

1 investor

Amplitude Therapeutics is a biotechnology company developing RNA-based medicines. The company is operating in stealth mode.

1 investor

1 investor

Amplitude VC creates, builds, and grows companies specializing in precision medicine to transform patient outcomes. The firm invests from ideation through patient care, focusing on innovations in human health.

1 investor

1 investor

Amporin Pharmaceuticals develops small-molecule drugs targeting toxic membrane pores formed by misfolded protein oligomers to treat neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Type 2 diabetes. The company aims to slow or halt disease progression and enable functional recovery in patients with protein misfolding and aggregation disorders.

1 investor

Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.

1 investor

AMR Bio develops XF-73, a first-in-class topical antimicrobial candidate in Phase 3 trials designed to prevent post-surgical infections, with the lead program targeting pre-operative decolonization in surgical settings. The company also advances dermal formulations for severe wound and skin infections.

1 investor

Curia is a CDMO (Contract Development and Manufacturing Organization) providing drug discovery, development, and manufacturing services across small molecules, generic APIs, sterile drug products, and biologics for biopharma companies.

1 investor

AMSlab is a biotechnology company focused on research, development, and innovation in analytical methods and quality control. The company develops solutions for detecting and identifying compounds across healthcare, food safety, marine toxins, and related biotech applications.

1 investor

AMSilk produces biotech-derived silk protein yarns for textile applications including fashion, accessories, and automotive interiors, using fermentation-based bioprocessing instead of traditional sericulture. The company's fibers are designed to match or exceed conventional silk performance while reducing water consumption, land use, and carbon emissions.

1 investor

AMW GmbH is a specialty pharmaceutical company that develops biodegradable drug delivery systems for controlled release of medications, with production facilities in Germany. It has two approved implant products, Goserelin and Leuprorelin, distributed worldwide through local and global pharmaceutical partners.

1 investor

Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme. The company addresses unmet clinical needs in addiction treatment through novel pharmacotherapies.

1 investor

1 investor

A drug discovery company focused on medicinal chemistry and preclinical research across multiple therapeutic areas.

1 investor

Everlife Analisa Resources is a laboratory and scientific solutions distributor founded in 1999, providing instruments, chemistries, consumables, software, and technical services to life sciences, analytical testing, and diagnostic markets across Asia. The company serves scientists, research institutions, biotechnology firms, and industries including pharmaceuticals, food, and chemicals.

1 investor

AnalytiChem manufactures and distributes laboratory chemicals and reference materials, including certified reference materials, elemental and organic standards, prepared culture media, high-purity acids, and instrument consumables. It serves scientists and laboratories across the mining, petroleum, environmental, food, and life sciences industries.

1 investor

Anatomiz3D develops patient-specific surgical planning solutions and tissue engineering products using 3D printing and bioprinting technologies for the healthcare industry. The company aims to improve surgical outcomes and eventually reduce organ transplant dependency through customized medical interventions.

1 investor

Anavex Life Sciences is a clinical-stage biopharmaceutical company developing oral therapeutics for central nervous system disorders, including Alzheimer's disease, Rett syndrome, and Fragile X syndrome. Its lead compound is ANAVEX 2-73 (blarcamesine), targeting early Alzheimer's and neurodevelopmental rare diseases.

1 investor

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable. It is building a proprietary pipeline of therapeutic programs targeting autoimmune diseases and cancer, with headquarters in Leiden, Netherlands and an R&D hub in Heidelberg, Germany.

1 investor

Andson Biotech develops analytical tools for the analysis of biotherapeutics, aimed at supporting the discovery and development of biologic drugs.

1 investor

AndzonBio operates a suite of thematic "pipeline builder" studios that accelerate the industrial development of academic life sciences projects into biotech companies, focusing on specific therapeutic areas such as cardiovascular/renal/metabolic disorders and neurological disorders. Launched by AdBio Partners and Inserm Transfert, it provides expert support, R&D budgets, and validation to turn academic programs into viable therapeutics companies.

1 investor

Andzonbio1 is a biotech start-up developing therapeutics and building a pipeline, supported by public and private funding sources in France. The company is backed by Inserm Transfert and AdBio partners, both focused on life sciences innovation and early-stage therapeutic investments.

1 investor